Benzinga | Apr 9, 2021 11:04AM EDT

Northland Capital Markets Upgrades Zimmer Biomet Holdings to Outperform, Raises Price Target to $200

Northland Capital Markets analyst Jason Wittes upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Market Perform to Outperform and raises the price target from $165 to $200.